TAGWORKS PHARMACEUTICALS
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. Tagworks develops In vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. The company’s facilities are located at the Radboud University Medical Center in Nijmegen. Founded in 2011, Tagworks is a spin-out of Philips Healthcare, and originates from Philips’ molecular imaging expertise.
TAGWORKS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-01-01
Address:
Nijmegen, Gelderland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.tagworkspharma.com
Total Employee:
11+
Status:
Active
Contact:
+31 6 25 02 15 25
Email Addresses:
[email protected]
Total Funding:
65 M USD
Technology used in webpage:
Person Schema CrUX Dataset Gravatar Profiles CrUX Top 50m
Similar Organizations
analog Intelligence
AI strategy in Healthcare and Biotech
Bgm Pharmaceuticals
Bgm Pharmaceuticals is a privately owned Biotechnology company
Chemotargets
Chemotargets is a computationally-oriented biotech company
De Novo Pharmaceuticals
De Novo Pharmaceuticals is an emerging computational drug design company.
Diartis Pharmaceuticals
Diartis Pharmaceuticals is a privately held biopharmaceutical company.
EnVivo Pharmaceuticals
EnVivo Pharmaceuticals, a privately-held biotech company
Fibrex Medical
Fibrex Medical is a privately held company
Indevex AB
Indevex AB is a science-based and privately owned biotech company.
Invent Pharmaceuticals
Invent Pharmaceuticals is an innovative biotech company
Current Advisors List
Current Employees Featured
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series A - Tagworks Pharmaceuticals
Gilde Healthcare
Gilde Healthcare investment in Series A - Tagworks Pharmaceuticals
OostNL
OostNL investment in Series A - Tagworks Pharmaceuticals
Ysios Capital
Ysios Capital investment in Series A - Tagworks Pharmaceuticals
Meneldor
Meneldor investment in Series A - Tagworks Pharmaceuticals
Lightstone Ventures
Lightstone Ventures investment in Series A - Tagworks Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Tagworks Pharmaceuticals
BIF Partners
BIF Partners investment in Seed Round - Tagworks Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-10-01 | Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive Officer |
Official Site Inspections
http://www.tagworkspharma.com Semrush global rank: 7.05 M Semrush visits lastest month: 899
- Host name: webcluster2.webpod12-cph3.one.com
- IP address: 46.30.213.44
- Location: Copenhagen Denmark
- Latitude: 55.6786
- Longitude: 12.5589
- Timezone: Europe/Copenhagen
- Postal: 1052
More informations about "Tagworks Pharmaceuticals"
Pioneers of Click-to-Release - Tagworks Pharmaceuticals
Jun 22, 2023 Conventional ADCs are limited to suitable internalizing targets, which are not necessarily expressed by every cancer type and cancer cell. We are leveraging our Click-to …See details»
Tagworks Pharmaceuticals - Crunchbase Company …
Organization. Tagworks Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +31 6 25 02 15 25; …See details»
Ken Mills - Tagworks Pharmaceuticals
Ken Mills is our CEO and is a more than 20+-year veteran of the biotechnology and pharmaceutical industries. Prior to joining Tagworks, he was the founding Chief Executive …See details»
Tagworks Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Jun 21, 2023 www.tagworkspharma.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Tagworks Pharmaceuticals Announces $65 Million in …See details»
Tagworks Pharmaceuticals - LinkedIn
Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by ...See details»
Tagworks Pharmaceuticals - Products, Competitors, Financials, …
Tagworkspharma.com. Overview & Products; Financials; People; Founded Year 2011. Stage Series A | Alive. Total Raised $65M. Last Raised $65M | 1 yr ago. ... Law was elevated to SVP …See details»
Tagworks Pharmaceuticals - Company Profile - Tracxn
Nov 5, 2024 Tagworks Pharmaceuticals - Developer of antibody-drug-conjugates. Raised a total funding of $65M over 4 rounds from 9 investors. Founded by Marc Robillard, Raffaella Rossin …See details»
Tagworks Pharmaceuticals - Craft
Tagworks Pharmaceuticals is a biotech company that develops antibody-based imaging and therapy. Its technology enables the actuation of tagged antibodies through selective chemical …See details»
Tagworks Pharmaceuticals - BCF Career
Tagworks Pharmaceuticals is a privately held biotech company based in Nijmegen, the Netherlands, supported by a robust group of investors. Using proprietary in vivo click …See details»
Tagworks Company Profile 2024: Valuation, Funding & Investors
Tagworks General Information Description. Developer of antibody-based imaging and therapy technology designed to improve the efficacy of cancer therapies. The company's technology …See details»
Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive …
Oct 1, 2024 For more information, visit us at www.tagworkspharma.com. Contact Media and Investors Sarah Sutton/Maeve Conneighton Argot Partners (212) 600-1902 …See details»
Tagworks Pharmaceuticals Appoints Ken Mills as Chief Executive …
Oct 1, 2024 For more information, visit us at www.tagworkspharma.com. Contact Media and Investors Sarah Sutton / Maeve Conneighton Argot Partners (212) 600-1902 [email protected]See details»
Gilde Healthcare company Tagworks Pharmaceuticals Appoints …
Oct 1, 2024 For more information, visit us at www.tagworkspharma.com. About Gilde Healthcare Gilde Healthcare is a transatlantic specialist investment firm managing over €2.6 billion across …See details»
Tagworks - Gilde Healthcare
Jun 22, 2023 Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is developing a unique and proprietary Click-to-Release platform to …See details»
Startup Tagworks raises $65M to make ‘click-to-release’ cancer …
Jun 22, 2023 Tagworks aims to go after solid tumor targets that, like TAG72, are hard to reach because they’re not internalized into cancer cells. Its platform borrows from "click chemistry," …See details»
Join us in our mission - Tagworks Pharmaceuticals
The Tagworks team is a group of dedicated, passionate individuals working together to leverage our Click-to-Release technology to deliver safer, more effective cancer therapies to patients in …See details»
Tagworks Pharmaceuticals announces $64 Million in ... - Gilde …
Jun 22, 2023 Tagworks Pharmaceuticals BV (“Tagworks”), the Dutch pioneer of Click-to-Release chemistry designed to deliver more effective and safer systemic therapies, today announced a …See details»
Why this pharma org is embracing a flexible working environment
4 hours ago In the last few years, HR has increasingly found itself caught between leadership that wants workers back in the office and employees who are seeking more flexible working …See details»
Our Technology - Tagworks Pharmaceuticals
May 24, 2023 Our platform is compatible with small molecules, peptides, and larger biomolecules, such as antibodies and antibody fragments, and covers a wide range of toxin …See details»
News - Tagworks Pharmaceuticals
Jul 6, 2024 News and events. The 17th Annual European Life Sciences CEO Forum will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel.See details»